Which drugs are most likely to be approved in Non-infectious Uveitis?

The decision in Europe follows an accelerated approval by the FDA earlier this year. Image credit: Shutterstock / Ekaterina Markelova. The European Commission (EC) has

Sanofi and De­nali Ther­a­peu­tics’ part­ner­ship ran in­to yet an­oth­er stum­bling block af­ter their ALS pro­gram failed a Phase II study. DNL788 did not achieve the

The FTC on Mon­day filed an am­i­cus brief in My­lan Phar­ma­ceu­ti­cals’ an­titrust law­suit al­leg­ing that Sanofi abused the FDA’s Or­ange Book to de­lay and block